Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers (Major) | 92 | 6.5% |
| Current Price (03/19) | $138.44 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 81,424.8 | |||
| Sales Growth Forecast | 4.7% | |||
| Net Profit Margin | 27.5% | |||
| Projected Shares Outstanding | 2,531.25 | |||
| EPS - Five year Forecast | $11.12 | |||
| Average P/E Ratio | 15.0 | |||
| Projected Average Price | $166.85 | |||
| Price Appreciation (Annualized) | 3.8% | |||
| Annual Dividend Yield | 2.7% | |||
| Projected Annual Return | 6.5% | |||
| Quality | ||||
| Financial Strength | 99 | 24.9 | ||
| EPS Stability | 98 | 24.5 | ||
| Industry Sales Growth Rate | 8.0% | 7.3 | ||
| Industry Net Profit Margin | 22.5% | 15.3 | ||
| Calculated Quality Rating | 71.9 | |||
| Fool CAPS | ||||
Total Players
13616
Outperforms
511
Underperforms
All-Stars (3123)
3056
Outperforms (98%)
67
Underperforms
|
||||
| Fundamental Data Updated: 02/15/2019 | ||||